Impact of five annual rounds of mass drug administration with diethylcarbamazine and albendazole on Wuchereria bancrofti infection in American Samoa

American Journal of Tropical Medicine and Hygiene

Volumn 78, Issue 6, 2008, Pages 924-928

  Liang, Jennifer L ^b   King, Jonathan D ^c   Ichimori, Kazuyo ^d   Handzel, Thomas ^a   Pa'au, Molisamoa ^e   Lammie, Patrick J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b DeKalb County Board of Health   (United States)

^c CARTER CENTER   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e American Samoa Department of Health   (American Samoa)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; PARASITE ANTIGEN;

ADOLESCENT; ADULT; AGED; AMERICAN SAMOA; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG EFFICACY; FEMALE; FILARIASIS; FOLLOW UP; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; TREATMENT OUTCOME; WUCHERERIA BANCROFTI;

WUCHERERIA BANCROFTI;

EID: 47049116083     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2008.78.924     Document Type: Article

References (22)

1. Murray WD, 1948. Filariasis studies in American Samoa. Naval Med Bull 48: 327-341.
2. Ciferri F, Siliga N, Long G, Kessel JF, 1969. A filariasis-control program in American Samoa. Am J Trop Med Hyg 18: 369-378.
3. Kessel JF, Siliga N, Tompkins H Jr, Jones K, 1970. Periodic mass treatment with diethylcarbamazine for the control of filariasis in American Samoa. Bull World Health Organ 43: 817-825.
4. Reid EC, Kimura E, 1993. Microfilaria prevalence of diurnally subperiodic Wuchereria bancrofti among people having a medical check-up in American Samoa in the past 17 years. J Trop Med Hyg 96: 118-123.
5. Weil GJ, Lammie PJ, Weiss N, 1997. The ICT filariasis test: a rapid-format antigen test for diagnosis of Bancroftian filariasis. Parasitol Today 13: 401-404.
6. Gyapong JO, Kyelem D, Kleinschmidt I, Agbo K, Ahouandogbo F, Gaba J, Owusu-Banahene G, Sanou S, Sodahlon YK, Biswas G, Kale OO, Molyneux DH, Roungou JB, Thomson MC, Remme J, 2002. The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries. Ann Trop Med Parasitol 96: 695-705.
7. Burkot TR, Taleo G, Toeaso V, Ichimori K, 2002. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities. Ann Trop Med Parasitol 96: S61-S69.
8. Burkot TR, Ichimori K, 2002. The PacELF programme: will mass drug administration be enough? Trends Parasitol 18: 109-115.
9. World Health Organization, 2005. Monitoring and Epidemiologi cal Assessment of the Programme to Eliminate Lymphatic Filariasis at Implementation Unit Level. Geneva: World Health Organization.
10. Kimura E, Penaia L, Spears FS, 1985. The efficiency of annual single-dose treatment with diethylcarbamazine citrate against diurnally subperiodic bancroftian filariasis in Samoa. Bull World Health Organ 63: 1097-1106.
11. Esterre P, Pilchart C, Sechan Y, Nguyen NL, 2001. The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Trop Med Int Health 6: 190-195.
12. Bockarie MJ, Tisch DJ, Kastens W, Alexander NDE, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW, 2002. Mass treatment to eliminate filariasis in Papua New Guinea. N Engl J Med 347: 1841-1848.
13. Fraser M, Taleo G, Taleo F, Yaviong J, Amos M, Babu M, Kalkoa M, 2005. Evaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach. Am J Trop Med Hyg 73: 753-758.
14. Beau De Rochars M, Kanjilal S, Direny AN, Radday J, LaFontant JG, Mathieu E, Rheingans RD, Haddix AC, Streit T, Beach MJ, Addiss DG, Lammie PJ, 2005. The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration. Am J Trop Med Hyg 73: 888-894.
15. Ramaiah KD, Das PK, Vanamail P, Pani SP, 2003. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes. Trop Med Int Health 8: 1082-1092.
16. Ramzy RMR, El Setouhy M, Ahmed ES, Abd Elaziz KM, Farid HA, Shannon WD, Weil GJ, 2006. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 367: 992-999.
17. Lammie PJ, Weil GJ, Noordin R, Kalirak P, Steel C, Goodman D, Lakshmikanthan VB, Ottesen EA, 2004. Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial. Filaria J 3: 9-13.
18. Weil GJ, Ramzy RMR, 2007. Diagnostic tools for filariasis elimination programs. Trends Parasitol 23: 78-82.
19. Kimura E, Penaia L, Spears FS, 1985. Epidemiology of subperiodic bancroftian filariasis in Samoa 8 years after control by mass treatment with diethylcarbamazine. Bull World Health Organ 63: 869-880.
20. Ichimori K, 2001. Entomology of the filariasis control programme in Samoa, Aedes polynesiensis and Ae. samoanus. Med Ent Zool 52: 11-21.
21. Bryan JH, Southgate BA, 1976. Some observations on filariasis in Western Samoa after mass administration of diethylcarbamazine. Trans R Soc Trop Med Hyg 70: 39-48.
22. Gelband H, 1994. Diethylcarbamazine salt in the control of lymphatic filariasis. Am J Trop Med Hyg 50: 655-662.